|
NMNAT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10019999999267E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.382500E-04 |
| Normal-vs-Stage2 |
1.258260E-02 |
| Normal-vs-Stage3 |
4.66160000001103E-06 |
| Normal-vs-Stage4 |
7.561900E-04 |
| Stage1-vs-Stage2 |
4.978200E-01 |
| Stage1-vs-Stage3 |
2.095800E-03 |
| Stage1-vs-Stage4 |
6.156300E-02 |
| Stage2-vs-Stage3 |
9.049700E-02 |
| Stage2-vs-Stage4 |
1.880380E-01 |
| Stage3-vs-Stage4 |
8.576000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11419999962948E-07 |
| Normal-vs-AfricanAmerican |
3.636200E-03 |
| Normal-vs-Asian |
5.121600E-02 |
| Caucasian-vs-AfricanAmerican |
8.279200E-01 |
| Caucasian-vs-Asian |
1.389600E-01 |
| AfricanAmerican-vs-Asian |
1.730390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.71480000047353E-07 |
| Normal-vs-Female |
2.208400E-04 |
| Male-vs-Female |
5.667200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.353100E-04 |
| Normal-vs-Extreme_Weight |
1.51832999999435E-05 |
| Normal-vs-Obese |
6.45479999999976E-05 |
| Normal-vs-Extreme_Obese |
5.860800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.841600E-01 |
| Normal_Weight-vs-Obese |
9.957600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.072100E-02 |
| Extreme_Weight-vs-Obese |
8.650600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.127640E-01 |
| Obese-vs-Extreme_Obese |
1.034780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.080700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.56899999999416E-05 |
| Normal-vs-Age(61-80Yrs) |
3.91450000000182E-05 |
| Normal-vs-Age(81-100Yrs) |
2.015600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.053000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.175370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.753800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.988800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.743000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.922600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.235000E-04 |
| Normal-VS-Type2 PRCC |
1.59479999999323E-05 |
| Normal-VS-KIRP CIMP |
1.62569957495862E-12 |
| Normal-VS-Unclassified PRCC |
1.114240E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.370100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.54080001482748E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
9.950800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.72710000026599E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.571970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.96620000012271E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.75410000039456E-07 |
| Normal-vs-N1 |
3.39049999187324E-09 |
| Normal-vs-N2 |
9.9496000327548E-10 |
| N0-vs-N1 |
8.198900E-03 |
| N0-vs-N2 |
3.264200E-02 |
| N1-vs-N2 |
3.017000E-01 |
|
|
